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Abstract
Background: Climbers on the summit of Mt. Everest are exposed to extreme hypoxia, and the
physiological implications are of great interest. Inferences have been made from alveolar gas
samples collected on the summit, but arterial blood samples would give critical information. We
propose a plan to insert an arterial catheter at an altitude of 8000 m, take blood samples above this
using an automatic sampler, store the samples in glass syringes in an ice-water slurry, and analyze
them lower on the mountain 4 to 6 hours later.
Results: A preliminary design of the automatic sampler was successfully tested at the White
Mountain Research Station (altitude 3800 m – 4300 m). To determine how much the blood gases
changed over a long period, rabbit blood was tonometered to give a gas composition close to that
expected on the summit (PO2 4.0 kPa (30 mmHg), PCO2 1.3 kPa (10 mmHg), pH 7.7) and the blood
gases were measured every 2 hours for 8 hours both at sea level and 3800 m. The mean changes
were PO2 +0.3 to +0.4 kPa (+2 to +3 mmHg), PCO2 0 to +0.13 kPa (+1 mmHg), pH -0.02 to -0.04,
base excess -0.7 to -1.2 mM. In practice the delay before analysis should not exceed 4 to 6 hours.
The small paradoxical rise in PO2 is presumably caused mainly by contamination of the blood with
air.
Conclusion: We conclude that automatic arterial blood sampling at high altitude is technically
feasible and that the changes in the blood gases over a period of several hours are acceptably small.
Background
There is good reason to believe that climbers at extreme
altitudes, for example on the summit of Mt. Everest, are
very close to their limit of tolerance to hypoxia. The com-
bination of extreme hypoxemia combined with an
extraordinary degree of respiratory alkalosis indicates a
degree of physiological derangement of otherwise normal
healthy people that is possibly unique.
During the 1981 American Medical Research Expedition
to Everest (AMREE), alveolar gas samples taken on the
summit, and at altitudes down to 8000 m, showed that
the summit alveolar PO2 and PCO2 values were about 4.7
kPa (35 mmHg) and 1 kPa (7.5 mmHg), respectively.
When these data were combined with measurements of
base excess (BE) in venous blood drawn the following
morning at an altitude of 8050, the calculated arterial
blood gases on the summit were PO2 3.7 kPa (28 mmHg),
PCO2 1 kPa (7.5 mmHg) and pH 7.7–7.8 [1]. No relevant
measurements have been made on the summit in the last
25 years but some measurements of alveolar PO2 at 8000
m altitude are consistent with the AMREE results [2].
Published: 08 March 2006
BMC Physiology2006, 6:3 doi:10.1186/1472-6793-6-3
Received: 29 December 2005
Accepted: 08 March 2006
This article is available from: http://www.biomedcentral.com/1472-6793/6/3
© 2006Catron et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 6
(page number not for citation purposes)
BMC Physiology 2006, 6:3 http://www.biomedcentral.com/1472-6793/6/3However, in the long-term low pressure chamber experi-
ments Operation Everest II [3] and COMEX '97 [4], the
results for the "summit" showed a lower alveolar PO2,
higher arterial PCO2, and lower pH which can probably
be explained by a lesser degree of acclimatization.
Apart from the physiological interest of understanding
this extreme environment, the results are important for
assessing the risks incurred by the many people who now
attempt to climb Mt. Everest. Furthermore, severe hypox-
emia is a feature of many patients in the intensive care
unit and results may throw light on related problems here.
In addition to the blood acquired during rest, it is planned
to collect samples immediately after exercise. These will
indicate whether the arterial PO2 falls even further as
might be expected from diffusion limitation across the
pulmonary blood-gas barrier. Another important meas-
urement will be blood lactate levels during rest and imme-
diately after exercise. Previous measurements at extreme
altitudes by Cerretelli and others [5] suggest that at alti-
tudes over about 7500 m, there will be no increase in
blood lactate concentrations as a result of exercise, a phe-
nomenon known as the "lactate paradox" [6], see [7] for a
recent review. This has never been tested under field con-
ditions at these extreme altitudes. Finally, it will be of
great interest to see to what extent the derangement of
blood gases alters the chemistry profile of the blood. For
example, does the severe respiratory alkalosis reduce the
concentration of ionized calcium? Such a change may
lead to tetany in the climber as possibly experienced by
Habeler during the first ascent of Everest without supple-
mentary oxygen. He stated "this feeling of being outside
myself was interrupted for only a few moments. Cramp in
my right hand bent my fingers together and tore me vio-
lently back to reality" [8].
At this time other groups are interested in obtaining arte-
rial samples very high on Mt. Everest [9]. However, there
are a number of limitations to drawing and analyzing
blood in these extreme conditions. Arteropuncture
requires some skill, and has more serious associated com-
plications than venopuncture. It is probably not feasible
to perform serial radial artery punctures at extreme alti-
tude via conventional techniques. Furthermore, though
portable blood gas and chemistry analyzers exist, they
require temperature stability to function reliably. Such
controlled conditions would not be immediately availa-
ble to climbers at the time of sample acquisition. There-
fore, the samples must be stored in some manner. It is
known that arterial samples stored on ice (near 0°C) have
slow internal gas and chemistry changes. However, this
has never been formally validated for the periods of time
required on Mt. Everest (up to 6 hours). Siggaard-
Andersen [10] studied the changes in blood chilled in ice
water but limited the studies to 3 hours. Kelman and
Nunn [11] also looked at the time courses of blood gases
but only in blood that cooled spontaneously, and only for
up to one hour. Our approach to these problems is to
insert an arterial catheter at an altitude of about 8000 m,
take several blood samples above this including on the
summit using an automatic sampler (actuated by the sub-
ject pressing a switch), store the samples in oiled glass
syringes in an ice-water slurry, and analyze the samples
lower on the mountain.
This study describes a proof-of-concept device for auto-
mated blood sampling which may be actuated by a
climber without technical expertise. In addition we meas-
ured the changes in blood gases in blood with a gas com-
position near that expected on Everest that was stored
near 0°C for up to 8 hours.
Methods
Automatic blood sampler
A prototype automated arterial blood sampler (Figure 1)
was designed and built in collaboration with the Depart-
ment of Mechanical Engineering, University of California
San Diego. This prototype was tested using animal blood
in the laboratory and also in the field at the White Moun-
tain Research Station (altitude 3800 m – 4300 m). In
order to simulate the effects of normal arterial blood pres-
sure, blood was exposed to a pressure of 17.3 kPa (130
Automatic arterial blood samplerFigure 1
Automatic arterial blood sampler. Schematic represen-
tation of the automatic arterial blood sampler. See text for 
explanation.Page 2 of 6
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sphygmomanometer. The device was evaluated for suc-
cessful serial sample collection in the field and successful
automated flushing of the system with heparinized saline
(in order to prevent clotting of the tubing or catheter). The
proof-of-concept device was built to show that automated
blood sampling in the field is feasible. The construction of
the final equipment that could be used in the hostile envi-
ronment of the Everest summit would need much more
development.
The sampling device (see Figure 1) relies on two small per-
istaltic pumps. First the system is primed with heparinized
saline. When the climber presses a switch, the three-way
valve is turned to connect the catheter to the syringes and
pump A pulls blood from the radial artery towards the
waste reservoir. After the saline in the dead space of the
tubing has been cleared, a servo then opens a pinch valve
at the syringe tip (located between the artery and the waste
reservoir), and the spring loaded syringe is released, draw-
ing 2 ml of blood. The pinch valve is then closed, and
pumps B and A flush the main line with heparinized
saline into the waste reservoir. Between sample collec-
tions, pump B flushes the catheter with heparinized saline
at predetermined intervals to prevent coagulation. In the
version shown in Figure 1 there are four syringes but this
number can be increased as required. The sequence of
operations is controlled by an electronic chip.
The apparatus consists of two separate units. First, a small
box about 3 cm × 3 cm × 5 cm is located on the dorsal
aspect of the climber's forearm a few cm above the wrist.
This contains the three-way valve shown on Figure 1 and
is connected to the indwelling radial arterial catheter. A
tube then runs up the arm through the sleeve to a second
box about 10 cm × 15 cm × 5 cm which is located on the
front of the chest under the down clothing of the climber.
The tube connecting the two boxes contains two polyeth-
ylene tubes and electrical wires to actuate the solenoid in
the wrist box. The chest box is thermally insulated and
contains the syringes shown in Figure 1 which are sur-
round by an ice-water slurry. The box also contains the
two peristaltic pumps and the two plastic bag reservoirs.
In addition the box houses the solenoid-driven pinch
valves, the activators to release the spring-loaded syringes,
the chip controller, and the battery pack to power the
units.
The total weight of the prototype was 2.2 kg. We used 5 ml
syringes even though the sample was only 2 ml because
this meant a shorter plunger movement for the springs.
The polythene tubing had a 2.4 mm internal diameter,
and the battery pack consisted of 4 rechargeable NiCad
cells. However it should be emphasized that this was a
proof-of-concept device and that producing a robust piece
of equipment that would work in the more challenging
environment of Mt. Everest would require additional
design work. Extensive testing in a cold room would be
necessary, and also with the subject exercising.
The proposed experimental plan is to have the radial
artery catheter inserted by an M.D. in a well-lighted,
warmed, special tent on the South Col (altitude about
8000 m). Prior to the expedition, the ulnar artery supply
to the hand should be checked using an Allen test, and if
there is any doubt about this angiography might be con-
sidered. The catheter and all tubing and other compo-
nents of the equipment that would come into contact
with the heparinized saline used for flushing the catheter
would be carried up in presterilized packs and incorpo-
rated into the apparatus in the high tent. The operator
who inserts the catheter would have an abundant supply
of breathing oxygen. Arterial blood samples would be
taken at this time during rest and exercise. Then the
climber going to the summit would take two or three sam-
ples on the summit, and two or three more on the way
down to the Col. When he/she returns to the South Col
camp the catheter would be removed by the M.D., the
blood samples placed in a special insulated box filled with
an ice-water slurry, and the samples taken rapidly down to
a lower camp where the analyzing equipment is located.
A possible site for this would be at an altitude of about
6300 m in the Western Cwm where the main AMREE lab-
oratory was located. Experience on AMREE showed that it
was possible to get blood samples down from the South
Col to this laboratory within about 4 hours. A possible
blood analyzer is the i-Stat (Abbott, East Windsor, NJ).
Special precautions need to be taken to prevent the rea-
gents from freezing while in the laboratory or en route to
it.
It is acknowledged that arterial catheter insertion in such
a remote, hostile environment has risks. Close attention
to sterile precautions needs to be given and the operator
would have practiced the technique extensively. The sub-
ject would climb with a companion who would be aware
of the possible complications. The wrist on the catheter-
ized side might be lightly splinted, and a special glove,
possibly with electrical heating, could be worn. At any
time the catheter could be removed and bleeding stopped
using local pressure.
Blood studies
Rabbit blood was tonometered to a gas composition close
to that expected on the summit of Mt Everest. The mean
blood gas values after tonometering were: PO2 3.76 kPa
(28.2 mmHg), PCO2 1.45 kPa (10.9 mmHg), pH 7.73.
Rabbit blood was chosen because of the abundant supply
of fresh blood. The blood gas changes due to metabolism
in the storage syringes are caused by white blood cells andPage 3 of 6
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these as human blood [12]. Samples were stored in lubri-
cated glass syringes with matching plungers and barrels
(as used in the prototype sampling device), and main-
tained at near 0°C in an ice-water slurry for 8 hours. An
Instrumentation Laboratory Synthesis Clinical Analyzer
and CO-Oximeter (Instrumentation Laboratory Com-
pany. Lexington, MA) were used to measure the PO2,
PCO2, pH, base excess, and oxygen saturation. Measure-
ments of oxygen saturation were only made at sea level
because of technical problems.
Two different measurement protocols were used:
1. Measurements were made at time zero and subse-
quently every 2 hours to develop a time course of gas and
chemistry changes.
2. Measurements were made at time zero and after 8 hours
to determine the total gas and chemistry changes.
Protocol 1 was conducted at sea level (n = 8). Protocol 2
was conducted both at sea level (n = 7) and an altitude of
3800 m (n = 11) in order to determine whether ambient
barometric pressures and therefore oxygen partial pres-
sures would affect the changes observed in the stored
blood.
Statistics
Data from protocol 1 were analyzed using a one-tailed z-
test to determine whether results at each time point varied
significantly from zero change. Data from protocol 2 were
analyzed in the same manner. Additionally, a two-tailed t-
test was performed to determine significant differences
between the samples analyzed at sea level and those meas-
ured at 3800 m. Significance was accepted at p < 0.05.
Results
The prototype automatic sampling device successfully
drew both non-pressurized and pressurized blood in the
laboratory and in the field for up to 4 consecutive cycles
(the number of syringes in this proof-of-concept model).
The device also successfully performed periodic flushing
of the attached catheter, and disposal of waste fluids into
the waste reservoir.
Time course studies (protocol 1) showed small but meas-
urable and approximately linear changes for three varia-
bles: PO2, pH, and BE (Figure 2). These variables also
showed statistically significant deviations from zero at all
time-points (p values ranged from < 0.0001 to 0.022). It
can be seen that there was a small steady rise in PO2 and
small falls in pH and BE. During the time course studies,
PCO2 changes were within the instrument error for blood
gas electrodes and were not statistically significant (p =
Changes in arterial blood gases over 8 hours for protocol 1Figur  2
Changes in arterial blood gases over 8 hours for protocol 1. Mean changes over 8 hours, measured every 2 hours (pro-
tocol 1): (a) pH, (b) PCO2, (c) PO2, (d) Base Excess (BE). Note the different scales. PO2, pH, and BE show changes outside the 
error range for the blood analyzer. However, PCO2 variations are within the range of instrument error. Ranges represent ± 1 
SD.
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problems with data collection during the experiment.
Measurements made at the beginning and end of the 8
hour period (protocol 2) showed measurable and statisti-
cally significant changes in all variables (p < 0.0001 to
0.01). However, the observed changes were small com-
pared to the expected instrument error of blood gas ana-
lyzers. There were no significant differences between data
collected at sea-level and data collected at 3800 m (p =
0.24 – 0.55) (Figure 3).
Discussion
The prototype sampling device used in this study has sev-
eral limitations, including relatively large size and weight
and delicate components. However, as a proof-of-concept
device it performed admirably. We were able to draw
blood samples over the course of several hours while the
device successfully flushed the lines at predetermined
intervals. With further development, it will be possible to
significantly refine the device, making it both smaller and
more robust for field studies.
The tonometry data presented above indicate that there
are small but measurable changes in blood stored at near
0°C for 8 hours. However, PCO2 and pH showed changes
that are small compared to the accuracy of blood gas ana-
lyzers. For example, PCO2, which might be expected to
rise due to continued metabolism, was seen to rise less
than 0.11 kPa (0.8 mmHg) in all trials – a negligible
change.
Changes in base excess are consistent with continued low
level production of metabolic acids. As described below,
it seems likely that these metabolic byproducts are respon-
sible for some of the other observed changes in the sam-
ples.
Interestingly, rather than a decrease in PO2 and oxygen
saturation, as may have been expected from continuing
metabolism, both values were seen to rise slightly in the
samples over time. These changes may be due to at least
two factors. We used oiled glass syringes with matched
plungers and barrels, which we feel to be the storage
method most resistant to contamination by ambient air.
However, in an environment with a relatively high ambi-
ent PO2 there may be no way to completely eliminate con-
tamination over several hours. In a low pressure
environment (such as on Mt. Everest), this contamination
might be expected to be less due to the decreased PO2 in
the air. It is interesting to note though, that there was no
significant difference in the changes in PO2 at 3800 m
compared to sea level.
Additionally, as small amounts of metabolic acid are pro-
duced through continuing metabolism of leucocytes and
platelets, a rise in PO2 of up to 0.13 kPa (1 mmHg) can be
attributed to the effects of this acid on hemoglobin-oxy-
gen dissociation [13,14]. Hence, as pH drops and BE
becomes increasingly negative in these samples, the
observed PO2 increases slightly because of the reduction
of the P50. In practice, the delay between sample acquisi-
tion and analysis should be less than 6 hours. The general
Changes in blood gases over 8 hours for protocol 2Figur  3
Changes in blood gases over 8 hours for protocol 2. Average blood gas and chemistry change over the course of 8 hours 
(protocol 2), and comparison of changes measured at sea level and at 3800 m. Units are dependent on the variable being meas-
ured. Note that SO2 data were collected only at sea level. Ranges represent ± 1 SD.Page 5 of 6
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conclusion is that the overall changes in these samples
were small enough to allow relatively accurate and relia-
ble assessment of blood gas composition over the antici-
pated period of time.
Conclusion
Arterial blood gases on the summit of Mt. Everest would
give exceptionally interesting information about this
extreme environment. The automated arterial blood sam-
pler that has been described here is technically feasible
although of course the whole experiment is very ambi-
tious. The changes in the blood gases over a period of sev-
eral hours are acceptably small. The device might also be
useful in other extreme environments.
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